![]() |
In association with
|
|
Forward to a colleague |
||
Access Full Stories A recent report has detailed the challenges facing the pharma industry as the generic flood gates open, with the constant advice to start planning early still apparently not heeded by a bewildering number of firms... Read Drug industry spend twice as much on marketing as on R&D The pharma industry spends almost twice as much promoting its drugs as it does trying to develop them, according to a new study... Read Crucell, Sanofi mix it up with rabies cocktail deal Dutch firm Crucell last week announced that it has entered into an agreement with vaccine specialist Sanofi Pasteur for its next generation rabies antibody cocktail... Read Pharma packagers all wrapped up Several pharmaceutical packaging players completed deals in time for the holidays, with Schott, Gerresheimer and Alcoa all announcing developments in the closing days of 2007... Read FDA approval for Skye, Sciele blood pressure med Despite a two month extension of the PDUFA date by the US Food and Drug Administration (FDA), Sciele and SkyePharma this week announced the approval of their controlled release formulation of high blood pressure... Read |
||||||||||||||||||
All News Headlines for: January | December | November |
||||||||||||||||||
Premier event for excipient manufacturers and end-users Europe's only dedicated forum on issues affecting the excipients sector is just two months away. Don't miss your chance to hear the latest on key topics such as supply chain integrity, counterfeiting, excipient master files and REACH... Click Here | ||||||||||||||||||
|
Related Industry News WuXi PharmaTech makes its first acquisition WuXi PharmaTech, China's contract research titan, has orchestrated its first acquisition, gaining biologics capabilities and a base in the US... Read Galapagos scores first oncology contract Galapagos' services arm has scored another lucrative contract from big pharma - its first in the field of oncology - as it continues to broaden its experience... Read New drug target leaves lung cancer cells alone, lonely and dying It seems even tumour cells can get lonely; scientists have discovered that by cutting off a key gene, lung cancer tumour cells are left 'homeless' and they can't survive on their own... Read Quintiles in $3bn investment deal One Equity Partners (OEP), the private equity arm of JPMorgan Chase, is in the process of selling its stake in Quintiles for a reported sum of over $3bn... Read
|
||||||||||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@In-PharmaTechnologist.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2008 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||